Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: Results of the Heinz Nixdorf recall study

Atherosclerosis

Volumn 232, Issue 2, 2014, Pages 339-345

  Lehmann, Nils ^a   Möhlenkamp, Stefan ^a,b   Mahabadi, Amir A ^a   Schmermund, Axel ^c   Roggenbuck, Ulla ^a   Seibel, Rainer ^d   Grönemeyer, Dietrich ^e   Budde, Thomas ^f   Dragano, Nico ^g   Stang, Andreas ^h   Mann, Klaus ⁱ   Moebus, Susanne ^a   Erbel, Raimund ^a   Jöckel, Karl Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Krankenhaus Bethanien   (Germany)

^c Cardioangiological Center Bethanien   (Germany)

^d Diagnosticum Mülheim   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

^f ALFRIED KRUPP KRANKENHAUS   (Germany)

^g Department of Orthopedic Surgery   (Germany)

^h MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

ⁱ UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acceleration of calcification onset; Coronary artery calcification; Smoking behavior

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

ACCELERATION OF CALCIFICATION ONSET; CORONARY ARTERY CALCIFICATION; SMOKING BEHAVIOR;

AGED; BLOOD PRESSURE; CALCINOSIS; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROBABILITY; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892864191     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.045     Document Type: Article

References (28)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. NEJM 1992, 326:242-250.
2. Erbel R., Möhlenkamp S., Moebus S., et al. Heinz Nixdorf recall study investigative group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf recall study. JACC 2010, 56:1397-1406.
3. Polonsky T.S., McClelland R.L., Jorgensen N.W., et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010, 303:1610-1616.
4. Möhlenkamp S., Lehmann N., Moebus S., et al. Quantification of coronary athero-sclerosis and inflammation to predict coronary events and all-cause mortality. JACC 2011, 57:1455-1464.
5. Kondos G.T., Hoff J.A., Sevrukov A., et al. Electron beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003, 107:2571-2576.
6. LaMonte M.J., FitzGerald S.J., Church T.S., et al. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am J Epidemiol 2005, 162:421-429.
7. Taylor A.J., Bindeman J., Feuerstein I., Cao F., Brazaitis M., O'Malley P.G. Coronary calcium independently predicts incident premature coronary heart disease over measured cardio-vascular risk factors: mean three-year outcomes in the prospective army coronary calcium (PACC) project. JACC 2005, 46:807-814.
8. Bellasi A., Lacey C., Taylor A.J., et al. Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta- and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am J Cardiol 2007, 100:409-414.
9. Erbel R., Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J 2012, 33:1201-1213.
10. Raggi P., Callister T.Q., Shaw L.J., et al. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 2004, 24:1272-1277.
11. Raggi P., Cooil B., Shaw L.J., et al. Progression of coronary calcium on serial EBT scanning is greater in patients with future myocardial infarction. Am J Cardiol 2003, 92:827-829.
12. Raggi P., Cooil B., Ratti C., Callister T.Q., Budoff M. Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension 2005, 46:238-243.
13. Cassidy A.E., Bielak L.F., Zhou Y., et al. Progression of subclinical coronary athero-sclerosis: does obesity make a difference?. Circulation 2005, 111:1877-1882.
14. Kawakubo M., LaBree L., Xiang M., et al. Race-ethnic differences in the extent, prevalence, and progression of coronary calcium. Ethn Dis 2005, 15:198-204.
15. Kronmal R.A., McClelland R.L., Detrano R., et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the multi-ethnic study of atherosclerosis (MESA). Circulation 2007, 115:2722-2730.
16. Mehrotra R., Budoff M., Christenson P., et al. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int 2004, 66:2022-2031.
17. Snell-Bergeon J.K., Hokanson J.E., Jensen L., et al. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care 2003, 26:2923-2928.
18. Schmermund A., Möhlenkamp S., Berenbein S., et al. Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. Atherosclerosis 2006, 185:177-182.
19. Min J.K., Lin F.Y., Gidseg D.S., et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal?. JACC 2010, 55:1110-1117.
20. Jöckel K.H., Lehmann N., Jaeger B.R., et al. Smoking cessation and subclinical athero-sclerosis. Results from the Heinz Nixdorf recall study. Atherosclerosis 2009, 203:221-227.
21. Schmermund A., Möhlenkamp S., Stang A., et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf recall study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 2002, 144:212-218.
22. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
23. Reiner Z., Catapano A.L., De Backer G., et al. ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2011, 32:1769-1818.
24. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of CHD using risk factor categories. Circulation 1998, 97:1837-1847.
25. Wang X.L., Greco M., Sim A.S., Duarte N., Wang J., Wilcken D.E. Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis 2002, 162:391-397.
26. Wang X.L., Sim A.S., Wang M.X., Murrell G.A., Trudinger B., Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 2000, 471:45-50.
27. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease - an update. JACC 2004, 43:1731-1737.
28. Ezzati M., Henley J., Thun M.J., Lopez A.D. Role of smoking in global and regional cardiovascular mortality. Circulation 2005, 112:489-497.